Japan’s government has approved an application for a clinical test of treatment for an intractable blood disease using iPS cells, which can grow into any type of body tissue.
Japan’s government has approved an application for a clinical test of treatment for an intractable blood disease using iPS cells, which can grow into any type of body tissue.
A health ministry panel on Friday gave the go-ahead to the application by a team at Kyoto University for the test for aplastic anemia. People with the disease have blood platelet deficiency and are prone to internal bleeding.
